Blanca D. Ayllon-Lopez
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
SARS-CoV-2 ORF7a drives mitochondrial dysfunction via PDK4 activation and complex I inhibition.
Journal: Cell reports
Published: December 23, 2025
Hidden players of COVID-19: the evolving roles of SARS-CoV-2 accessory proteins.
Journal: Frontiers in immunology
Published: October 16, 2025
Induction of the Inflammasome by the SARS-CoV-2 Accessory Protein ORF9b, Abrogated by Small-Molecule ORF9b Homodimerization Inhibitors.
Journal: Journal of medical virology
Published: June 11, 2024
Metabolic and mitochondria alterations induced by SARS-CoV-2 accessory proteins ORF3a, ORF9b, ORF9c and ORF10.
Journal: Journal of medical virology
Published: November 10, 2023
SARS-CoV-2 accessory proteins involvement in inflammatory and profibrotic processes through IL11 signaling.
Journal: Frontiers in immunology
Published: May 10, 2023
Biomarkers of erlotinib response in non-small cell lung cancer tumors that do not harbor the more common epidermal growth factor receptor mutations.
Journal: International journal of clinical and experimental pathology
Published: December 05, 2014
Cancer stem cells and cisplatin-resistant cells isolated from non-small-lung cancer cell lines constitute related cell populations.
Journal: Cancer medicine
Published: March 06, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026